Drugs Made In America Acquisition II Corp. (DMIIU) Net Income towards Common Stockholders (2025)
Drugs Made In America Acquisition (DMIIU) posted quarterly Net Income towards Common Stockholders of $2.1 million for Q4 2025, up 25270.18% quarter-over-quarter from -$8207.0 in Q3 2025.
Drugs Made In America Acquisition II Corp. (DMIIU) Net Income towards Common Stockholders (2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIU) has reported Net Income towards Common Stockholders for 1 consecutive years, with $2.1 million the latest figure, recorded in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.07 Mn |
| Sep 30, 2025 | -8,207.00 |